[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Page 434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00175]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Operation of a Facility for the
Study of Infectious Agents, Vaccines, and Antimicrobials in Adult
and Pediatric Human Subjects (N01).
Date: February 11, 2019.
Time: 9:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Dharmendar Rathore, Ph.D., Senior Scientific
Review Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G30, National Institutes of Health/NIAID, 5601
Fishers Lane, Drive, MSC 9834, Bethesda, MD 20892-9834, 240-669-
5058, [email protected].
This meeting notice is being published less than 15 days in
advance of the meeting due to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 17, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00175 Filed 1-25-19; 8:45 am]
BILLING CODE 4140-01-P